3 terminated. 1 Not applicable, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
| Phase 4 | 1 | Terminated 1 |
Follow Impella LP 2.5: new trials by email Literature Review of Impella LP 2.5 trials Research Report on Impella LP 2.5
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MINI-AMI: Minimizing Infarct Size With Impella 2.5 Following PCI for Acute Myocardial Infarction Impella 2.5 support, Standard of care (Control) - ST-elevation Myocardial Infarction | Not applicable | Terminated | Abiomed Inc. | 5 | 2011-04-01 | 2019-05-13 |
| Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability Impella LP 2.5, Intra-Aortic Balloon Pump - Acute Myocardial Infarction | Phase 3 | Terminated | Abiomed Inc. | 1 | 2008-07-01 | 2011-03-21 |
| Comparison of Standard Treatment Versus Standard Treatment Plus Extracorporeal Life Support (ECLS) in Myocardial Infarction Complicated With Cardiogenic Shock Extra-Corporeal Life Support -Impella 2.5 - Myocardial Infarction, Shock, Cardiogenic | Phase 4 | Terminated | University Hospital, Caen | 19 | 2005-06-01 | 2010-08-02 |
Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Heart Diseases (1) · Ischemia (1) · Myocardial Infarction (1) · Myocardial Ischemia (1) · ST Elevation Myocardial Infarction (1) · Shock, Cardiogenic (1) · Vascular Diseases (1)
Abiomed Inc. (2) · University Hospital, Caen (1)
France (1) · United States (1)
Ajay Kirtane, MD (1) · Jeffrey Moses, MD (1) · Massimo Massetti, MD (1) · William O'Neill, M.D. (1)